Merck’s recent clinical trials with combo therap
Post# of 148279
This cuts both ways. 2 scenarios:
1) Merck is now really desperate to find a combo drug so they can market a new formulation and thus extend some patent protection, so maybe they will want to try it with LeronlimabYamab.
2) There is something about Keytruda that makes other drugs ineffective when combined with Keytruda.
Of course, there is also Scenario 3
3) They don’t give a rip about CYDY and Leronlimab